Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan von Gunten

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Pharmacology|April 29, 2020
Secondary-Type Carbohydrate Modification as a Driver of Epithelial-Mesenchymal Transition and Features of Cancer Stem CellsStephan von Gunten
Pharmacology|December 11, 2019
The Future of Pharmacology: Towards More Personalized Pharmacotherapy and Reverse Translational ResearchStephan von Gunten
Pharmacology|September 6, 2020
Inflamm-Aging: Arginase-II as Stage Setter in Age-Related Adipose Tissue InflammationStephan von Gunten
International Archives of Allergy and Immunology|November 7, 2019
Allergy and Atopic Diseases: An Update on Experimental EvidenceDaniëlle Verschoor, Stephan von Gunten
Pharmacology|March 31, 2022
Diversification of IgA Antibody Specificities by Mild Chemical Modification?Guy Gorochov, Stephan von Gunten
Journal of Clinical Immunology|April 21, 2010
Cell death modulation by intravenous immunoglobulinStephan von Gunten, Hans-Uwe Simon
International Archives of Allergy and Immunology|November 14, 2018
Recent Advances in Experimental AllergyOlivia Joan Adams, Stephan von Gunten
Cell Death & Disease|December 14, 2020
Linking glucocorticoid-induced osteoporosis to osteoimmunologyStephan von Gunten, Hans-Uwe Simon
Pharmacology|January 18, 2021
Targeting the Laminated Layer of Echinococcus multilocularis as a Potential Therapeutic StrategyRichard D Cummings, Stephan von Gunten
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 4, 2006
Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytesStephan von Gunten, Hans-Uwe Simon
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Pharmacology|April 29, 2020
Secondary-Type Carbohydrate Modification as a Driver of Epithelial-Mesenchymal Transition and Features of Cancer Stem CellsStephan von Gunten
Pharmacology|December 11, 2019
The Future of Pharmacology: Towards More Personalized Pharmacotherapy and Reverse Translational ResearchStephan von Gunten
Pharmacology|September 6, 2020
Inflamm-Aging: Arginase-II as Stage Setter in Age-Related Adipose Tissue InflammationStephan von Gunten
International Archives of Allergy and Immunology|November 7, 2019
Allergy and Atopic Diseases: An Update on Experimental EvidenceDaniëlle Verschoor, Stephan von Gunten
Pharmacology|March 31, 2022
Diversification of IgA Antibody Specificities by Mild Chemical Modification?Guy Gorochov, Stephan von Gunten
Journal of Clinical Immunology|April 21, 2010
Cell death modulation by intravenous immunoglobulinStephan von Gunten, Hans-Uwe Simon
International Archives of Allergy and Immunology|November 14, 2018
Recent Advances in Experimental AllergyOlivia Joan Adams, Stephan von Gunten
Cell Death & Disease|December 14, 2020
Linking glucocorticoid-induced osteoporosis to osteoimmunologyStephan von Gunten, Hans-Uwe Simon
Pharmacology|January 18, 2021
Targeting the Laminated Layer of Echinococcus multilocularis as a Potential Therapeutic StrategyRichard D Cummings, Stephan von Gunten
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 4, 2006
Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytesStephan von Gunten, Hans-Uwe Simon
Pageof 8